These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12010810)

  • 1. Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.
    Mitsiades N; Mitsiades CS; Poulaki V; Chauhan D; Richardson PG; Hideshima T; Munshi N; Treon SP; Anderson KC
    Blood; 2002 Jun; 99(11):4079-86. PubMed ID: 12010810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells.
    Mitsiades N; Mitsiades CS; Poulaki V; Anderson KC; Treon SP
    Blood; 2002 Mar; 99(6):2162-71. PubMed ID: 11877293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications.
    Mitsiades CS; Treon SP; Mitsiades N; Shima Y; Richardson P; Schlossman R; Hideshima T; Anderson KC
    Blood; 2001 Aug; 98(3):795-804. PubMed ID: 11468181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability.
    Poulaki V; Mitsiades CS; Joussen AM; Lappas A; Kirchhof B; Mitsiades N
    Am J Pathol; 2002 Dec; 161(6):2229-40. PubMed ID: 12466137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL).
    Robbins MA; Maksumova L; Pocock E; Chantler JK
    Endocrinology; 2003 Oct; 144(10):4616-25. PubMed ID: 12960048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias.
    Mitsiades N; Mitsiades CS; Poulaki V; Anderson KC; Treon SP
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1521-30. PubMed ID: 11772267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells.
    Stadheim TA; Suh N; Ganju N; Sporn MB; Eastman A
    J Biol Chem; 2002 May; 277(19):16448-55. PubMed ID: 11880365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M; Weller M
    Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB-mediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis.
    Shou Y; Li N; Li L; Borowitz JL; Isom GE
    J Neurochem; 2002 May; 81(4):842-52. PubMed ID: 12065643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
    Hideshima T; Chauhan D; Hayashi T; Podar K; Akiyama M; Mitsiades C; MItsiades N; Gong B; Bonham L; de Vries P; Munshi N; Richardson PG; Singer JW; Anderson KC
    Cancer Res; 2003 Dec; 63(23):8428-36. PubMed ID: 14679006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
    Mitsiades CS; Mitsiades N; Poulaki V; Schlossman R; Akiyama M; Chauhan D; Hideshima T; Treon SP; Munshi NC; Richardson PG; Anderson KC
    Oncogene; 2002 Aug; 21(37):5673-83. PubMed ID: 12173037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent manner.
    Tatetsu H; Okuno Y; Nakamura M; Matsuno F; Sonoki T; Taniguchi I; Uneda S; Umezawa K; Mitsuya H; Hata H
    Mol Cancer Ther; 2005 Jul; 4(7):1114-20. PubMed ID: 16020669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
    Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
    Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappa B as a therapeutic target in multiple myeloma.
    Hideshima T; Chauhan D; Richardson P; Mitsiades C; Mitsiades N; Hayashi T; Munshi N; Dang L; Castro A; Palombella V; Adams J; Anderson KC
    J Biol Chem; 2002 May; 277(19):16639-47. PubMed ID: 11872748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nuclear translocation of transcription factor nuclear factor-kappa B induces FAS- as well as tumour necrosis factor-alpha-mediated apoptosis through downregulation of a conserved family of inhibitor of apoptosis 1.
    Imanishi T; Hano T; Takarada S; Nishio I
    Clin Exp Pharmacol Physiol; 2003 Mar; 30(3):133-9. PubMed ID: 12603340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crebanine, an aporphine alkaloid, sensitizes TNF-α-induced apoptosis and suppressed invasion of human lung adenocarcinoma cells A549 by blocking NF-κB-regulated gene products.
    Yodkeeree S; Pompimon W; Limtrakul P
    Tumour Biol; 2014 Sep; 35(9):8615-24. PubMed ID: 24867094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.
    Bhardwaj A; Sethi G; Vadhan-Raj S; Bueso-Ramos C; Takada Y; Gaur U; Nair AS; Shishodia S; Aggarwal BB
    Blood; 2007 Mar; 109(6):2293-302. PubMed ID: 17164350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
    Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
    J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.
    Mitsiades N; Mitsiades CS; Poulaki V; Chauhan D; Richardson PG; Hideshima T; Munshi NC; Treon SP; Anderson KC
    Blood; 2002 Jun; 99(12):4525-30. PubMed ID: 12036884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.